Help us help you by taking our second annual Debt survey and you could win R3 000.
Culture change from below is the only way to overcome poverty, says Leopold Scholtz.
After the tech euphoria of 2013, the fast-moving sector has hit a speed bump.
AstraZeneca, the British drugs giant, would not be drawn over reports it faces a mega takeover bid from Pfizer, alongside news that its profits had halved.
Swiss pharmaceuticals giant Novartis has posted a jump in first-quarter net profit, driven largely by the sale of a blood transfusion diagnostics unit.
British pharmaceutical giant AstraZeneca has announced a halving of net profits in the first quarter, following the loss of exclusivity for key drugs.
Novartis and GlaxoSmithKline have agreed to trade more than $20bn worth of assets to bolster their best businesses and exit weaker ones.
Shares in European drugmakers received a shot in the arm amid a flurry of activity.
Swiss drugmaker Novartis is transforming its business by exchanging certain
assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly
A report says Pfizer may come back to bid for British drug company AstraZeneca after an earlier takeover approach was rejected.
Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as it seeks to build a new sales model.
GlaxoSmithKline is facing a criminal investigation in Poland for allegedly
bribing doctors to promote its lung drug Seretide.
Investors are confident that Sun Pharma's $3.2bn purchase of rival Ranbaxy is a great deal, banking on Sun's history of nursing ailing companies back to health.
Governments who stockpile Roche's flu medicine Tamiflu are wasting billions on a drug whose effectiveness is in doubt, researchers say.
Your slogan encapsulates the essence of what your company is about, says an expert.
A Fin24 user wants to know the tax implications of becoming an independent contractor.
Debt hunger has become stronger even as many people face insolvency, says an expert.
Help us help you by taking our second annual Debt survey and you could win R3 000!
Taxpayers must ensure their Sars affairs are in order.
Advice for a Fin24 user on how to deal with an incompetent debt counsellor.
A user has observed shrinkflation since the1970s and says it's nothing new.
A Fin24 user overcame his unemployment crisis by taking matters into his own hands.
Resolutions have been passed at an extraordinary general meeting of Adcock Ingram shareholders to appoint three new board members.
The World Health Organisation wants a "concerted effort" to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus.
The EFF in Gauteng will focus all its energy on improving the lives of the poor, the party's premier candidate Dali Mpofu says.
Yes, the miners are suffering
No, the miners were exploited long enough
A pay hike won't resolve mining sector ills
Previous results ·
Suggest a vote
Get your financial questions answered.
News delivered really simply.
Easy-to-use personal finance tools.
You choose what you want.
Your opinion on you, me and everyone.
Get us in your home, on your television.
Lost? Confused? Problems? Let us help you.